JAKARTA – The Indonesian Ministry of Health and the UNDP SMILE carried out a nationwide Stock Opname on 2-6 January 2023. Stock Opname is an activity to match the amount of real physical vaccine stocks with the recording of vaccine data on the Electronic Immunization and Logistics Monitoring System (SMILE) application. It is very important to ensure accountability for managing COVID-19 and routine immunization vaccines and supporting logistics allocated for the 2022 period.
The Stock Opname process is preceded by tracing the transaction records – namely, the reconciliation stage so that data discrepancies due to errors in recording on SMILE during Stock Opname can be avoided. The next stage is verification (desk) of reconciliation results and Stock Opname to obtain accurate data. In order to prevent discrepancies in the records, the vaccine logistics manager must always record the transactions, whether in issuing, receiving, ordering, or disposing of the vaccines through the SMILE application, carefully and in a timely manner.
Letters of the Directorate General of Disease Prevention and Control (P2P) No. HK.02.02/C/5961/2022 and the Director of Pharmaceutical Management and Services, Directorate General of Pharmaceuticals and Medical Devices No. FO.03.02/E.IV/5190/2022 confirms that Stock Opname is carried out not only for the COVID-19 vaccine but starting in 2023 this also applies to routine immunization vaccines. Based on the Letter, Stock Opname through the SMILE application must be carried out regularly by the community health centers and the Health Offices at the provincial, district, and municipal levels. The process is directly supervised by the Indonesian Ministry of Health.
According to the Director of Pharmaceutical Management and Services, Directorate General of Pharmaceuticals and Medical Devices, Ministry of Health of the Republic of Indonesia, Dina Sintia Pamela, the Stock Opname data will be used as a baseline to determine the amount of provision of the COVID-19 and Routine Immunization vaccines as well as its supporting logistics needed by the Provincial Health Offices by 2023.
Stock Opname will also assist the Central Government in verifying the availability of vaccines, also for its planning and procurement in a more accountable manner. The Stock Opname transactions and results recorded through SMILE serve as a reference and facilitate the audit process. As conveyed by the Head of Sub-Auditorship AKN VI (Main Auditorate of State Finance), the Supreme Audit Agency (BPK), Aulia Rahmat. “SMILE is the backbone for recording COVID-19 and non-COVID-19 vaccines. There is no application other than SMILE which the BPK can refer to in conducting audits,†said Aulia.
The Stock Opname results as of 6 January 2023 are as follows:
COVID-19 Vaccine
Routine Immunization Vaccine
